Literature DB >> 7599841

Added external resistance reduces oropharyngeal deposition and increases lung deposition of aerosol particles in asthmatics.

K Svartengren1, P Lindestad, M Svartengren, K Philipson, G Bylin, P Camner.   

Abstract

Mouth and throat, and regional lung deposition was estimated in fifteen asthmatic subjects for 3.6-microns (aerodynamic diameter) radiolabeled polytetrafluoroethylene (Teflon) particles inhaled at 0.5 L/s with and without added external resistance. Radioactivity was measured by a profile scanner. Behavior of the pharynx and larynx was assessed by fiberoptic laryngoscopy. Mean mouth and throat deposition was 22% (range, 13 to 47%) and 33% (range, 12 to 84%) with and without resistance (p < 0.05), respectively. A marked reduction in mouth and throat deposition (range, 20 to 44%), with a corresponding increase in lung deposition, was observed especially in the six subjects with mouth and throat deposition values > 30% at inhalation without resistance. Furthermore, a small (mean 8%) but significant (p < 0.05) increase in peripheral lung deposition, estimated as retention at 24 h, was found at inhalation with increased resistance. The fiberoptic examination showed wide intersubject variability in the pharynx and larynx, with tendencies toward higher mouth and throat deposition with pharyngeal narrowing, and significantly (p < 0.05) lower lung retention with laryngeal narrowing. Our results show that an external resistance reduces mouth and throat deposition and increases deposition and retention of aerosol particles in the lungs in asthmatic individuals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7599841     DOI: 10.1164/ajrccm.152.1.7599841

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

Review 1.  Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications.

Authors:  N R Labiris; M B Dolovich
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

2.  Suitability of the upper airway models obtained from MRI studies in simulating drug lung deposition from inhalers.

Authors:  T Ehtezazi; K W Southern; D Allanson; I Jenkinson; C O'Callaghan
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

3.  Effect of oropharyngeal length in drug lung delivery via suspension pressurized metered dose inhalers.

Authors:  T Ehtezazi; D R Allanson; I D Jenkinson; C O'Callaghan
Journal:  Pharm Res       Date:  2006-05-26       Impact factor: 4.200

4.  The interaction between the oropharyngeal geometry and aerosols via pressurised metered dose inhalers.

Authors:  T Ehtezazi; I Saleem; I Shrubb; D R Allanson; I D Jenkinson; C O'Callaghan
Journal:  Pharm Res       Date:  2009-11-10       Impact factor: 4.200

Review 5.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

Review 6.  Use of inhaler devices in pediatric asthma.

Authors:  Fernando Maria De Benedictis; David Selvaggio
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

7.  Delivery characteristics of a low-resistance dry-powder inhaler used to deliver the long-acting muscarinic antagonist glycopyrronium.

Authors:  Paul Colthorpe; Thomas Voshaar; Thomas Kieckbusch; Erika Cuoghi; Juergen Jauernig
Journal:  J Drug Assess       Date:  2013-02-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.